Clinical trial
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) EUropean Angiography Study
NCT01995500 is registered in ClinicalTrials.gov with Medinol Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) EUropean Angiography Study
- Lead sponsor
- Medinol Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 19, 2014
- Completion date
- June 17, 2020
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery stenosis